Integrase Inhibitors Market Is Estimated To Witness High Growth Owing To Increasing Demand for HIV Treatment and Rising Adoption of Combination Therapies
The global Integrase Inhibitors Market is estimated to be valued at US$ 29.34 billion in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Integrase inhibitors are a class of antiretroviral drugs used in the treatment of HIV infection. These inhibitors prevent the integration...
0 Comments 0 Shares 893 Views 0 Reviews
Sponsored